Kalbe Farma (KLBF IJ) - Rebalancing Growth
Kalbe Farma released reassuring results for 2021 with growth coming from prescription drugs and distribution but 2022 will see a recovery across...
256 Views
Kalbe Farma (KLBF IJ) - Oiling the Wheels of Health
Kalbe (KLBF IJ) remains a key proxy to healthcare, consumer health, and nutritionals in Indonesia, with an increasingly digital edge to its...
220 Views
Kalbe Farma (KLBF IJ)- Back to the Business of Health
Kable Farma remains a core healthcare proxy for Indonesia, coverings everything from prescription pharmaceuticals, consumer health, and...
385 Views
The Week That Was in ASEAN@Smartkarma - Indonesian Pharma, Del Monte, and Online Groceries Are Go.
The week that was in ASEAN@Smartkarma is filled with another eclectic mix of differentiated, substantive, and actionable insights from across South...
219 Views
Kalbe Farma (KLBF IJ) - An Increasingly Healthy Blend
Kalbe Farma is a core holding to play increasing health consciousness in Indonesia, with a strong portfolio of core brands, with valuations below...
220 Views